Atherosclerosis severity in patients with familial hypercholesterolemia: The role of T and B lymphocytes

Waleria Toledo Fonzar, Francisco Antônio Helfenstein Fonseca, Henrique Fonseca, Tuany P. Silva, Alfredo Augusto Eyer Rodrigues, Daniela Teixeira, Mayari Eika Ishimura, Maria Esther Rochael Coste, Carolina Nunes França, Henrique Tria Bianco,

Atherosclerosis Plus · 2022 · 10 citations · 29 references

DOIFull text

Open access

Concepts

Abstract

Background and aims: Familial hypercholesterolemia (FH) is characterized by lifelong exposure to high LDL-c concentrations and premature atherosclerotic cardiovascular disease; nevertheless, disease severity can be heterogeneous.We aimed at evaluating if the immune-inflammatory system could modulate atherosclerosis burden in FH. Methods: -ApoB-D) autoantibodies (IgM and IgG), lymphocytes subtypes, platelet, monocyte and endothelial microparticles (MP), IgM levels (circulating or produced by B1 cells) and cytokines in the supernatant of cultured cells were determined. Multiple linear regression models evaluated associations of these biomarkers with CAC and CAD-RADS scores. Results: = 0.049; 95% CI for B 0.000 to 0.053) was independent predictor. Conclusions: In subjects with FH, under high-intensity lipid-lowering therapy, age and CD4+T cells were associated to atherosclerosis burden.

References

29